T. Rowe Price Associates
OABI icon

T. Rowe Price Associates’s OmniAb OABI Stock Holding History

T. Rowe Price Associates’s Portfolio OABI Stock Details OABI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$122K Buy
77,040
+23,850
+45% +$43K ﹤0.01% 2952
2025
Q4 		$100K Hold
53,190
– – ﹤0.01% 2948
2025
Q3 		$86K Buy
53,190
+5,574
+12% +$10.2K ﹤0.01% 2949
2025
Q2 		$84K Buy
47,616
+8,299
+21% +$13.9K ﹤0.01% 2927
2025
Q1 		$95K Buy
39,317
+1,100
+3% +$3.6K ﹤0.01% 2827
2024
Q4 		$136K Buy
38,217
+7,950
+26% +$31.5K ﹤0.01% 2787
2024
Q3 		$129K Buy
30,267
+716
+2% +$3.1K ﹤0.01% 2772
2024
Q2 		$112K Buy
29,551
+2,708
+10% +$12.3K ﹤0.01% 2734
2024
Q1 		$146K Buy
26,843
+3,108
+13% +$17.9K ﹤0.01% 2700
2023
Q4 		$148K Buy
23,735
+2,238
+10% +$11K ﹤0.01% 2633
2023
Q3 		$112K Buy
21,497
+2,593
+14% +$13.8K ﹤0.01% 2640
2023
Q2 		$96K Buy
18,904
+4,819
+34% +$19.5K ﹤0.01% 2705
2023
Q1 		$52K Buy
14,085
+575
+4% +$2.17K ﹤0.01% 2788
2022
Q4 		$49K Buy
+13,510
New +$70.9K ﹤0.01% 2812

Other funds holding OABI

WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TL
TowerView LLC New York $155M AUM 30.14% 1-Year Est. Return

T. Rowe Price Associates's OABI Position: Q1 2026 in Review

T. Rowe Price Associates increased its OmniAb (OABI) stake by 45% in Q1 2026, buying an estimated $43K and bringing the position to 77,040 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #2952.

T. Rowe Price Associates first reported a position in OABI in Q4 2022 and has held it in 14 quarters since. The position peaked at $148K in Q4 2023. 128 funds tracked by Wall St. Rank hold OABI as of Q1 2026.

  • T. Rowe Price Associates held 77,040 shares of OmniAb worth $122K as of Q1 2026.
  • T. Rowe Price Associates bought 23,850 OmniAb shares in Q1 2026, an estimated $43K.
  • OmniAb made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2952 holding.
  • T. Rowe Price Associates first reported a position in OmniAb in Q4 2022 and has held it in 14 quarters since.
  • T. Rowe Price Associates's OmniAb position peaked at $148K in Q4 2023.
  • 128 funds tracked by Wall St. Rank held OmniAb as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.